Aspen Aerogels, Inc.

Informe Stock NYSE:ASPN

Capitalización de mercado: US$1.3b

Aspen Aerogels Crecimiento futuro

Future controles de criterios 5/6

Aspen Aerogels se prevé un crecimiento anual de los beneficios y los ingresos de 69% y 37.1% respectivamente. Se prevé que el BPA sea de grow en 69.9% al año. Se prevé que la rentabilidad de los fondos propios sea de 8.5% en 3 años.

Información clave

53.7%

Tasa de crecimiento de los beneficios

54.2%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals15.5%
Tasa de crecimiento de los ingresos31.2%
Rentabilidad financiera futura10.7%
Cobertura de analistas

Good

Última actualización10 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Analysts Have Made A Financial Statement On Aspen Aerogels, Inc.'s (NYSE:ASPN) Full-Year Report

Feb 15
Analysts Have Made A Financial Statement On Aspen Aerogels, Inc.'s (NYSE:ASPN) Full-Year Report

Recent updates

Health Check: How Prudently Does Aspen Aerogels (NYSE:ASPN) Use Debt?

Apr 05
Health Check: How Prudently Does Aspen Aerogels (NYSE:ASPN) Use Debt?

Aspen Aerogels: Impressive And Intriguing

Mar 25

Aspen Aerogels, Inc. (NYSE:ASPN) Looks Just Right With A 53% Price Jump

Mar 08
Aspen Aerogels, Inc. (NYSE:ASPN) Looks Just Right With A 53% Price Jump

Analysts Have Made A Financial Statement On Aspen Aerogels, Inc.'s (NYSE:ASPN) Full-Year Report

Feb 15
Analysts Have Made A Financial Statement On Aspen Aerogels, Inc.'s (NYSE:ASPN) Full-Year Report

Powering Up The EV Market: Mini Deep Dive On Aspen Aerogels

Jan 08

Why Investors Shouldn't Be Surprised By Aspen Aerogels, Inc.'s (NYSE:ASPN) 40% Share Price Surge

Dec 22
Why Investors Shouldn't Be Surprised By Aspen Aerogels, Inc.'s (NYSE:ASPN) 40% Share Price Surge

Aspen Aerogels: Phoenix Rising - Assessing The Shifts, Challenges, And Potential Future Triumphs

Nov 13

Aspen Aerogels (NYSE:ASPN) Is Making Moderate Use Of Debt

Nov 03
Aspen Aerogels (NYSE:ASPN) Is Making Moderate Use Of Debt

Aspen Aerogels: Margin Expansion But Still A Lot Of Uncertainties

Sep 28

The Price Is Right For Aspen Aerogels, Inc. (NYSE:ASPN) Even After Diving 25%

Aug 12
The Price Is Right For Aspen Aerogels, Inc. (NYSE:ASPN) Even After Diving 25%

Aspen Aerogels: Not Insulating Investors From The Cold

Jun 20

Is Aspen Aerogels (NYSE:ASPN) Weighed On By Its Debt Load?

Feb 26
Is Aspen Aerogels (NYSE:ASPN) Weighed On By Its Debt Load?

Aspen Aerogels Q4 results beat estimates, co guides FY 2023 revenue in-line

Feb 15

Aspen Aerogels: No Reason To Be In A Hurry, Ample Headwinds In 2023

Jan 08

Aspen Aerogels (NYSE:ASPN) Has Debt But No Earnings; Should You Worry?

Oct 27
Aspen Aerogels (NYSE:ASPN) Has Debt But No Earnings; Should You Worry?

Aspen Aerogels reports Q3 earnings miss; narrows FY22 earnings guidance

Oct 27

Is Aspen Aerogels (NYSE:ASPN) A Risky Investment?

Jul 16
Is Aspen Aerogels (NYSE:ASPN) A Risky Investment?

Aspen Aerogels soars ~56% following its decision to not advance with stock and debt offering

Jun 30

Aspen Aerogels: The Next Big Opportunity

Apr 28

Aspen Aerogels: Highly Speculative

Feb 22

Companies Like Aspen Aerogels (NYSE:ASPN) Are In A Position To Invest In Growth

Dec 24
Companies Like Aspen Aerogels (NYSE:ASPN) Are In A Position To Invest In Growth

Is Aspen Aerogels, Inc. (NYSE:ASPN) Worth US$44.4 Based On Its Intrinsic Value?

Oct 24
Is Aspen Aerogels, Inc. (NYSE:ASPN) Worth US$44.4 Based On Its Intrinsic Value?

Is Aspen Aerogels (NYSE:ASPN) Using Too Much Debt?

Sep 28
Is Aspen Aerogels (NYSE:ASPN) Using Too Much Debt?

Previsiones de crecimiento de beneficios e ingresos

NYSE:ASPN - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/2026845107-92N/A3
12/31/202559155-1081148
12/31/2024362-14-138329
12/31/2023239-46-218-43N/A
9/30/2023214-55-270-64N/A
6/30/2023190-71-335-94N/A
3/31/2023188-80-309-96N/A
12/31/2022180-83-272-94N/A
9/30/2022152-89-209-82N/A
6/30/2022146-68-113-51N/A
3/31/2022132-50-66-40N/A
12/31/2021122-37-32-19N/A
9/30/2021113-27-19-12N/A
6/30/2021107-26-13-7N/A
3/31/2021100-25-14-10N/A
12/31/2020100-22-13-10N/A
9/30/2020124-17-30N/A
6/30/2020135-12-5-2N/A
3/31/2020140-12-21N/A
12/31/2019139-15-3-1N/A
9/30/2019129-28-8-6N/A
6/30/2019117-32-8-4N/A
3/31/2019109-34-13-9N/A
12/31/2018104-34-12-9N/A
9/30/2018105-22-12-8N/A
6/30/2018108-19-8-5N/A
3/31/2018112-17-7-3N/A
12/31/2017112-19-11-5N/A
9/30/2017103-23N/A-4N/A
6/30/2017105-23N/A-1N/A
3/31/2017108-19N/A-5N/A
12/31/2016118-12N/A-1N/A
9/30/2016127-5N/A4N/A
6/30/2016129-4N/A1N/A
3/31/2016132-5N/A9N/A
12/31/2015123-6N/A5N/A
9/30/2015113-11N/A5N/A
6/30/2015107-11N/A6N/A
3/31/2015104-50N/A2N/A
12/31/2014102-66N/A7N/A
9/30/201499-64N/A2N/A
6/30/201495-75N/A-1N/A
3/31/201491-40N/A-8N/A
12/31/2013861N/A-14N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. tasa de ahorro: ASPN se prevé que sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.2%).

Beneficios frente mercado: ASPN se prevé que sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: ASPN se espera que sea rentable en los próximos 3 años.

Ingresos vs. Mercado: ASPNSe prevé que los ingresos de la empresa (37.1% al año) crezcan más deprisa que los del mercado US (8.1% al año).

Ingresos de alto crecimiento: ASPNSe prevé que los ingresos de la empresa (37.1% al año) crezcan más deprisa que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

Futura rentabilidad financiera (ROE): ASPNSe prevé que la Rentabilidad de los fondos propios de la empresa sea baja dentro de 3 años (8.5%).


Descubre empresas en crecimiento

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target